Colorado

Oregon: controversy over legal cannabis revenues

Posted on May 10th, 2017 by Global Ganja Report and tagged , , , , , , , .

OregonOregon voted to legalize cannabis way back in November 2014, but promises of state coffers filled with canna-dollars are apparently being held up by an arcane bureaucratic logjam. Newsweek just noted a May 5 report from Oregon's KWG News finding that the state has brought in close to $75 million in cannabis tax revenue since the start of 2016—yet not a penny has gone to actually closing Salem's yawning $1.6 billion budget deficit.

Hackers hit cannabis dispensary tracking software

Posted on January 12th, 2017 by Global Ganja Report and tagged , , , , , , .

Shadow WatchAmid all the current paranoia about hackers infiltrating the highest levels of American politics comes the disturbing news that software used by cannabis businesses in over 20 states was attacked and compromised. The story was reported both by the cannabis industry trade website Marijuana Business Daily and tech sites that monitor such attacks, including Hackbusters and DataBreaches. The software, known as MJ Freeway, is used for "seed-to-sale" tracking of cannabis in states that have legalized or passed medical marijuana laws. The Denver-based company said its main servers and backup system both went down the morning of Jan. 8, and remained offline as of the next afternoon.

Sessions testimony on cannabis: strategic ambiguity?

Posted on January 11th, 2017 by Bill Weinberg and tagged , , , , , , , .

Shadow WatchAfter the first day of Senate confirmation hearings for Jeff Sessions, president-elect Trump's choice to lead the US Justice Department, cannabis advocates are parsing his testimony for clues as to what the incoming administration's stance will be on whether to continue to give breathing room to state-level legalization and medical marijuana laws. The Los Angeles Times takes an ominous view, writing in a headline: "Sessions leaves door open to reviving federal war on pot."

Massachusetts to get country's biggest legal grow

Posted on December 29th, 2016 by Global Ganja Report and tagged , , , , , , , , .

MassachusettsDenver-based AmeriCann is planning to develop what will be the United States' largest medical marijuana facility in Freetown, Mass. At one million square feet, the Massachusetts Medical Cannabis Center is planned for a tract in the Bristol County town formerly slated for a brewery by the Boston Beer Co. Boston Business Journal reports that AmeriCann bought the property this fall for $4.475 million. AmeriCann CEO Tim Keogh said the facility will be "the place in the northeast US for the creation of a wide variety of exciting new advanced products for medical cannabis patients."

The cannabis question in Trump's America

BlackLivesMatterThe results of the Nov. 8 elections really indicate the schizophrenic nature of American political culture at this moment. Amid the fear and loathing over the election of the fascistic Donald Trump as president, big gains were registered for cannabis freedom. Voters in California approved Proposition 64, legalizing  up to an ounce for those 21 and older, and allowing individuals to grow up to six plants. The measure also permits retail sales and imposes a 15% tax. Similar measures passed in Massachusetts, Maine and Nevada, bringing the percentage of Americans living in states where cannabis is legal for adults up from five to 20 percent. Only Arizona's Proposition 205 was rejected by the voters.

Big pharma, alcohol fund anti-legalization drives —surprise!

Posted on October 26th, 2016 by Bill Weinberg and tagged , , , , .

Shadow WatchWho do you think is pouring money into the campaigns against the legalization initiaves that will go before the voters in five states next month? Well, an Oct. 22 exposé in The Guardian newspaper will confirm your most cyniical suspicions. In August, the pharmaceutical company Insys Therapeutics became the biggest donor to the campaign to defeat Arizona's Proposition 205, making a $500,000 donation to Arizonans for Responsible Drug Policy (ARDP). In making the donation, Insys cited concerns for child safety. But The Guardian points out the delicious irony: Insys manufactures Subsys, a prescription painkiller derived from fentanyl—a synthetic opioid that is up to 100 times more powerful than morphine. And the Phoenix New Times adds that Insys is under investigation in four states, including Arizona, for marketing practices related to Subsys that have allegedly resulted in patient deaths.

WikiLeaks reveals: alcohol industry promotes Congressional concern for cannabis

Posted on August 2nd, 2016 by Bill Weinberg and tagged , , , , , , , .

Shadow WatchIs the alcohol industry spending money to get members of Congress to pay attention to the problem of "marijuana-impaired driving"? That's the case made on the cannabis industry website Marijuana.com, where a blogger seems to have assiduously searched the famous WikiLeaks dump of DNC e-mails for any reference to our favorite herb. What they found was in the May 24, 2016 edition of Huddle, a daily e-newsletter for Capitol Hill insiders produced by the Politico website. That issue included a paid advertisement from the Wine & Spirits Wholesalers of America (WSWA), which read in part:

Contention over THC maximum proposals in Canada, Colorado

Posted on July 10th, 2016 by Global Ganja Report and tagged , , , , , , , .

CanadaAs Canada prepares to legalize cannabis nationwide, Ottawa is consulting citizens and stake-holders to shape the new policy. Among the proposals floated at a Vancouver Cannabis Hemp Conference this weekend was a measure to cap the THC content of approved strains. Not surprisingly, this met with a resounding negative from industry and advocates. "It's time for us to stop demonizing THC. We need policy that's based on both evidence and expertise," Hilary Black of the BC Compassion Club Society told the CBC.  "We have an opportunity in Canada right now to be leaders on the world stage and to do this right."

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman